Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Other financing activities: 2021-2024

Historic Other financing activities for Akebia Therapeutics (AKBA) over the last 3 years, with Dec 2024 value amounting to $1.3 million.

  • Akebia Therapeutics' Other financing activities fell 91.60% to $63,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $41.3 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2024, which is N/A change from last year.
  • Akebia Therapeutics' Other financing activities amounted to $1.3 million in FY2024, which was down 96.82% from $40.0 million recorded in FY2022.
  • Akebia Therapeutics' Other financing activities' 5-year high stood at $44.8 million during FY2021, with a 5-year trough of $1.3 million in FY2024.
  • Its 2-year average for Other financing activities is $20.6 million, with a median of $20.6 million in 2022.
  • Data for Akebia Therapeutics' Other financing activities shows a maximum YoY declined of 10.68% (in 2022) over the last 5 years.
  • Akebia Therapeutics' Other financing activities (Yearly) stood at $44.8 million in 2021, then declined by 10.68% to $40.0 million in 2022, then reached $1.3 million in 2024.